CORMCO's mission is to deploy patient capital and generate superior long-term investment returns while embracing stringent risk management methodologies.

CORMCO's public equity portfolio applies a fundamentally oriented and long-term investment approach. It invests in tech, biotech, and real estate companies that benefit from powerful secular growth trends, strong management teams, and impeccable financials statements. CORMCO's private equity portfolio invests in tech, biotech, and real estate growth companies already backed by solid institutional funding, namely investments ranging from Series C to pre-IPO equity, post-IPO equity, and post-IPO debt.

CORMCO has made notable early investments in several companies in the global tech, biotech, and real estate industies. Some of these investments include:

NVIDIA in 1999, a pioneer in the fields of artificial intelligence and graphics processing, and among the five most valuable companies the world.

BROADCOM in 1998, a global tech leader in the fields of artificial intelligence and semiconductor solutions, and among the 10 most valuable companies in the world.

DROPBOX in 2012, a smart workspace company that provides secure file sharing, collaboration, and storage solutions.

COINBASE in 2019, a cryptocurrency exchange and cryptocurrency wallet platform that allows users to buy, sell, and store various cryptocurrencies.

NATERA in 2018, a clinical genetic testing company that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health.

KARUNA in 2018,a biotech innovator at the forefront of addressing the unmet needs in the treatment of psychiatric and neurological conditions.

CORMCO has a track record of investing in leading AI companies, most notably its early investments in Nvidia and Broadcom. CORMCO leverages its industry expertise and network to identify emerging AI startups with outstanding founders, game changing offerings, and strong market potential.